Rewarding effect of the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice

Deborah (Deb) Finn, Tamara Phillips, Dobrina M. Okorn, Julia A. Chester, Christopher Cunningham

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The GABA(A)-receptor agonist neuroactive steroid 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) has anxiolytic and locomotor stimulant effects and shares some subjective properties with benzodiazepines. Barbiturates and ethanol, but there have been no studies of its reinforcing or rewarding effects. The present study examined the rewarding properties of 3α,5α-P using the conditioned place preference paradigm. Male DBA/2J mice received four pairings of a distinctive floor stimulus with 3α,5α-P (3.2, 10 or 17 mg/kg, IP) in an unbiased conditioning procedure. On alternate days a different distinctive floor was paired with vehicle. At the lowest dose (3.2 mg/kg), there was no difference between conditioning subgroups in preference for the drug-paired floor type, indicating an absence of place conditioning. However, a dose-dependent conditioned preference was evident at the higher doses as shown by the greater amount of time spent on the floor paired with 3α,5α-P. In addition, 3α,5α-P produced a dose-dependent increase in locomotor activity, which was significant following the 17 mg/kg dose. A control study showed no effect of the β-cyclodextrin vehicle on place conditioning in the absence of neurosteroid. These results provide the first demonstration that 3α,5α-P, an endogenous modulator of GABA(A) receptor function, possesses rewarding properties using the conditioned place preference paradigm.

Original languageEnglish (US)
Pages (from-to)261-264
Number of pages4
JournalPharmacology Biochemistry and Behavior
Volume56
Issue number2
DOIs
StatePublished - Feb 1997

Fingerprint

Steroids
GABA-A Receptor Agonists
Inbred DBA Mouse
Barbiturates
Anti-Anxiety Agents
Cyclodextrins
GABA-A Receptors
Locomotion
Benzodiazepines
Modulators
Neurotransmitter Agents
Ethanol
Demonstrations
pregnane-20-one
Pharmaceutical Preparations

Keywords

  • conditioned place preference
  • GABA(A)-receptor agonist
  • inbred mice
  • locomotor activity
  • neuroactive steroid
  • reward

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Rewarding effect of the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice. / Finn, Deborah (Deb); Phillips, Tamara; Okorn, Dobrina M.; Chester, Julia A.; Cunningham, Christopher.

In: Pharmacology Biochemistry and Behavior, Vol. 56, No. 2, 02.1997, p. 261-264.

Research output: Contribution to journalArticle

@article{0c63b1a08f9a477696ee6f0088398808,
title = "Rewarding effect of the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice",
abstract = "The GABA(A)-receptor agonist neuroactive steroid 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) has anxiolytic and locomotor stimulant effects and shares some subjective properties with benzodiazepines. Barbiturates and ethanol, but there have been no studies of its reinforcing or rewarding effects. The present study examined the rewarding properties of 3α,5α-P using the conditioned place preference paradigm. Male DBA/2J mice received four pairings of a distinctive floor stimulus with 3α,5α-P (3.2, 10 or 17 mg/kg, IP) in an unbiased conditioning procedure. On alternate days a different distinctive floor was paired with vehicle. At the lowest dose (3.2 mg/kg), there was no difference between conditioning subgroups in preference for the drug-paired floor type, indicating an absence of place conditioning. However, a dose-dependent conditioned preference was evident at the higher doses as shown by the greater amount of time spent on the floor paired with 3α,5α-P. In addition, 3α,5α-P produced a dose-dependent increase in locomotor activity, which was significant following the 17 mg/kg dose. A control study showed no effect of the β-cyclodextrin vehicle on place conditioning in the absence of neurosteroid. These results provide the first demonstration that 3α,5α-P, an endogenous modulator of GABA(A) receptor function, possesses rewarding properties using the conditioned place preference paradigm.",
keywords = "conditioned place preference, GABA(A)-receptor agonist, inbred mice, locomotor activity, neuroactive steroid, reward",
author = "Finn, {Deborah (Deb)} and Tamara Phillips and Okorn, {Dobrina M.} and Chester, {Julia A.} and Christopher Cunningham",
year = "1997",
month = "2",
doi = "10.1016/S0091-3057(96)00218-3",
language = "English (US)",
volume = "56",
pages = "261--264",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Rewarding effect of the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice

AU - Finn, Deborah (Deb)

AU - Phillips, Tamara

AU - Okorn, Dobrina M.

AU - Chester, Julia A.

AU - Cunningham, Christopher

PY - 1997/2

Y1 - 1997/2

N2 - The GABA(A)-receptor agonist neuroactive steroid 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) has anxiolytic and locomotor stimulant effects and shares some subjective properties with benzodiazepines. Barbiturates and ethanol, but there have been no studies of its reinforcing or rewarding effects. The present study examined the rewarding properties of 3α,5α-P using the conditioned place preference paradigm. Male DBA/2J mice received four pairings of a distinctive floor stimulus with 3α,5α-P (3.2, 10 or 17 mg/kg, IP) in an unbiased conditioning procedure. On alternate days a different distinctive floor was paired with vehicle. At the lowest dose (3.2 mg/kg), there was no difference between conditioning subgroups in preference for the drug-paired floor type, indicating an absence of place conditioning. However, a dose-dependent conditioned preference was evident at the higher doses as shown by the greater amount of time spent on the floor paired with 3α,5α-P. In addition, 3α,5α-P produced a dose-dependent increase in locomotor activity, which was significant following the 17 mg/kg dose. A control study showed no effect of the β-cyclodextrin vehicle on place conditioning in the absence of neurosteroid. These results provide the first demonstration that 3α,5α-P, an endogenous modulator of GABA(A) receptor function, possesses rewarding properties using the conditioned place preference paradigm.

AB - The GABA(A)-receptor agonist neuroactive steroid 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) has anxiolytic and locomotor stimulant effects and shares some subjective properties with benzodiazepines. Barbiturates and ethanol, but there have been no studies of its reinforcing or rewarding effects. The present study examined the rewarding properties of 3α,5α-P using the conditioned place preference paradigm. Male DBA/2J mice received four pairings of a distinctive floor stimulus with 3α,5α-P (3.2, 10 or 17 mg/kg, IP) in an unbiased conditioning procedure. On alternate days a different distinctive floor was paired with vehicle. At the lowest dose (3.2 mg/kg), there was no difference between conditioning subgroups in preference for the drug-paired floor type, indicating an absence of place conditioning. However, a dose-dependent conditioned preference was evident at the higher doses as shown by the greater amount of time spent on the floor paired with 3α,5α-P. In addition, 3α,5α-P produced a dose-dependent increase in locomotor activity, which was significant following the 17 mg/kg dose. A control study showed no effect of the β-cyclodextrin vehicle on place conditioning in the absence of neurosteroid. These results provide the first demonstration that 3α,5α-P, an endogenous modulator of GABA(A) receptor function, possesses rewarding properties using the conditioned place preference paradigm.

KW - conditioned place preference

KW - GABA(A)-receptor agonist

KW - inbred mice

KW - locomotor activity

KW - neuroactive steroid

KW - reward

UR - http://www.scopus.com/inward/record.url?scp=0031043365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031043365&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(96)00218-3

DO - 10.1016/S0091-3057(96)00218-3

M3 - Article

C2 - 9050083

AN - SCOPUS:0031043365

VL - 56

SP - 261

EP - 264

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -